Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA general NIH notice about the terminology transition appears above the 403 error page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0. The page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record, indicating an access or server issue that prevents viewing the study content.SummaryDifference0.5%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a minimal header and a Home link, indicating that access to the study information is blocked.SummaryDifference17%

- Check42 days agoChange DetectedThe page revision stamp changed from v3.6.6 to v3.7.0, indicating a version update to the page.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a newer version of the page. This appears to be a minor update to the page's documentation/versioning metadata rather than a substantive change to the study information.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.